RDZN vs. GOCO, FANH, EHTH, ZBAO, SLQT, TSI, MHLD, SWKH, PCB, and BLFY
Should you be buying Roadzen stock or one of its competitors? The main competitors of Roadzen include GoHealth (GOCO), Fanhua (FANH), eHealth (EHTH), Zhibao Technology (ZBAO), SelectQuote (SLQT), TCW Strategic Income Fund (TSI), Maiden (MHLD), SWK (SWKH), PCB Bancorp (PCB), and Blue Foundry Bancorp (BLFY). These companies are all part of the "finance" sector.
GoHealth (NASDAQ:GOCO) and Roadzen (NASDAQ:RDZN) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, earnings, risk, valuation, profitability, media sentiment, institutional ownership and dividends.
24.2% of GoHealth shares are owned by institutional investors. Comparatively, 24.7% of Roadzen shares are owned by institutional investors. 52.0% of GoHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
GoHealth has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, Roadzen has a beta of 0.86, suggesting that its share price is 14% less volatile than the S&P 500.
GoHealth received 39 more outperform votes than Roadzen when rated by MarketBeat users.
In the previous week, GoHealth had 3 more articles in the media than Roadzen. MarketBeat recorded 4 mentions for GoHealth and 1 mentions for Roadzen. GoHealth's average media sentiment score of 1.89 beat Roadzen's score of -0.37 indicating that Roadzen is being referred to more favorably in the news media.
GoHealth currently has a consensus price target of $13.00, suggesting a potential upside of 43.17%. Given Roadzen's higher probable upside, equities analysts plainly believe GoHealth is more favorable than Roadzen.
Roadzen has lower revenue, but higher earnings than GoHealth.
Roadzen has a net margin of 0.00% compared to Roadzen's net margin of -8.59%. GoHealth's return on equity of 0.00% beat Roadzen's return on equity.
Summary
GoHealth beats Roadzen on 6 of the 11 factors compared between the two stocks.
Get Roadzen News Delivered to You Automatically
Sign up to receive the latest news and ratings for RDZN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RDZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
